Jeffrey Bauer

Jeffrey Bauer has a strong background in the pharmaceutical industry, with over 23 years of experience in various roles. Jeffrey started their career at AAIPharma Services Corp. in 1994, where they worked in regulatory affairs. From there, they moved on to IVAX in 1997, serving as Director of Technical Affairs. In 2001, Jeffrey joined HEXAL AG / Eon Labs as Vice President of Business Development & Licensing, and later transitioned to Eon Labs as Vice President of Business Development. Jeffrey then joined Sandoz in 2005 as Vice President of Business Development before working at ChemWerth Inc. as President from 2010 to 2013. Following this, they became CEO/President of ProGenerix LLC, a virtual pharmaceutical development company. Most recently, Jeffrey has taken on the role of Chief Executive Officer at Midas Pharma, a mid-sized pharmaceutical company specializing in project management around pharmaceutical supply chains.

Jeffrey Bauer received a Bachelor of Applied Science (B.A.Sc.) in Biology, General from Tufts University in 1984. Jeffrey then pursued a Master of Science (MSc) in Forensic Chemistry from Duquesne University between 1984 and 1986. Subsequently, they obtained a Doctor of Philosophy (Ph.D.) in Pharmacology from the University of North Carolina at Chapel Hill from 1986 to 1992.